<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="740">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05151523</url>
  </required_header>
  <id_info>
    <org_study_id>0318-21-RMC</org_study_id>
    <nct_id>NCT05151523</nct_id>
  </id_info>
  <brief_title>Long-term Recurrence Rates of Atrial Fibrillation Following New-onset Atrial Fibrillation During ICU Admission</brief_title>
  <official_title>Long-term Recurrence Rates of Atrial Fibrillation Following New-onset Atrial Fibrillation During ICU Admission</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katia Orvin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Primary Objective of the study is to establish the One-year recurrence rates of atrial&#xD;
      fibrillation (AF) following new-onset atrial fibrillation during intensive care unit (ICU)&#xD;
      admission.&#xD;
&#xD;
      The Secondary Objective is a composite of death from cardiovascular causes, stroke (either&#xD;
      ischemic or hemorrhagic), or hospitalization with worsening of heart failure or recurrent AF.&#xD;
&#xD;
      The prevalence and recurrence rates of AF will be divided into sub-groups based on primary&#xD;
      ICU admission diagnosis.&#xD;
&#xD;
      All-cause mortality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be screened for atrial fibrillation during hospitalization in the intensive&#xD;
      care unit and will be followed until discharge. Once discharged home or to a rehabilitation&#xD;
      center, they will be invited to a routine follow-up clinic at RMC cardiology institute 4-6&#xD;
      weeks after hospital discharge. During the clinic visit, patients will be recruited to the&#xD;
      study follow-up plan.&#xD;
&#xD;
      The follow-up plan will consist of 3 clinical visits at 4-6 weeks, 6-months and 1 -year after&#xD;
      discharge.&#xD;
&#xD;
      The follow-up program will include a comprehensive screening for symptomatic and asymptomatic&#xD;
      atrial fibrillation events as following:&#xD;
&#xD;
      Patients will be provided with a home cellular-digital 12-lead ECG transmitter. They will be&#xD;
      instructed to conduct routine weekly transmission in order to record asymptomatic events as&#xD;
      well as to transmit at any time they suspect an event/feel symptoms (palpitations). Home&#xD;
      routine testing will be initiated and guided by a telephone call from a medical monitoring&#xD;
      center. A blinded, independent, on-call medical professional team will analyze the received&#xD;
      ECG.&#xD;
&#xD;
      A 48-hour Holter ECG will be performed at 6 months and 12 months after ICU discharge&#xD;
&#xD;
      Clinical visits will include 12 leads ECG, physical examination, vital signs, symptoms&#xD;
      evaluation for suspected AF events, questioning for hospital admissions, or any other&#xD;
      documented AF event. Patients will be asked to perform echocardiography as part of their&#xD;
      clinical evaluation. For both the study and control group, documented AF events will be&#xD;
      managed according to physician discretion based on clinical practice and guidelines.&#xD;
&#xD;
      Long-term follow-up- 3 years- data regarding recurrent events of AF, hospitalization due to&#xD;
      thromboembolic events, and mortality will be evaluated by telephone call or by matching&#xD;
      patient identification numbers with the Israeli National Population Register.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">December 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Recurrence rates of atrial-fibrillation following new-onset atrial-fibrillation during intensive care unit</measure>
    <time_frame>One-year</time_frame>
    <description>A positive ECG or Holter test for atrial fibrillation will be regarded as recurrence.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiovascular events</measure>
    <time_frame>3-years</time_frame>
    <description>A composite of death from cardiovascular causes, stroke (either ischemic or hemorrhagic), or hospitalization with worsening of heart failure or recurrent AF.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence rates of atrial-fibrillation</measure>
    <time_frame>3-years</time_frame>
    <description>The prevalence and recurrence rates of atrial-fibrillation divided into sub-groups based on primary ICU admission diagnosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>3-years</time_frame>
    <description>All-cause mortality will be monitored on clinical flow-up.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Atrial Fibrillation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with new-onset atrial-fibriltion using 30-second telemetry recording or&#xD;
        a 12 lead ECG indicating AF during general ICU hospitalization.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admitted to ICU over 24 hours&#xD;
&#xD;
          -  Diagnosed with new-onset atrial fibrillation&#xD;
&#xD;
          -  The patient survived the index hospitalization and was discharged home/ to a&#xD;
             rehabilitation center.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        • Previously documented atrial fibrillation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Katia Orvin, M.D</last_name>
    <phone>+972548001942</phone>
    <email>katiaorvin@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>LIOR FISHER, M.D</last_name>
    <phone>+972547440708</phone>
    <email>fisherlior1@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Boriani G, Fauchier L, Aguinaga L, Beattie JM, Blomstrom Lundqvist C, Cohen A, Dan GA, Genovesi S, Israel C, Joung B, Kalarus Z, Lampert R, Malavasi VL, Mansourati J, Mont L, Potpara T, Thornton A, Lip GYH; ESC Scientific Document Group . European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). Europace. 2019 Jan 1;21(1):7-8. doi: 10.1093/europace/euy110. Review.</citation>
    <PMID>29905786</PMID>
  </reference>
  <reference>
    <citation>January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014 Dec 2;130(23):2071-104. doi: 10.1161/CIR.0000000000000040. Epub 2014 Mar 28. Erratum in: Circulation. 2014 Dec 2;130(23):e270-1.</citation>
    <PMID>24682348</PMID>
  </reference>
  <results_reference>
    <citation>Kanji S, Williamson DR, Yaghchi BM, Albert M, McIntyre L; Canadian Critical Care Trials Group. Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients. J Crit Care. 2012 Jun;27(3):326.e1-8. doi: 10.1016/j.jcrc.2011.10.011. Epub 2012 Jan 4.</citation>
    <PMID>22226423</PMID>
  </results_reference>
  <results_reference>
    <citation>McIntyre WF, Um KJ, Cheung CC, Belley-Côté EP, Dingwall O, Devereaux PJ, Wong JA, Conen D, Whitlock RP, Connolly SJ, Seifer CM, Healey JS. Atrial fibrillation detected initially during acute medical illness: A systematic review. Eur Heart J Acute Cardiovasc Care. 2019 Mar;8(2):130-141. doi: 10.1177/2048872618799748. Epub 2018 Nov 7.</citation>
    <PMID>30403364</PMID>
  </results_reference>
  <results_reference>
    <citation>Lubitz SA, Yin X, Rienstra M, Schnabel RB, Walkey AJ, Magnani JW, Rahman F, McManus DD, Tadros TM, Levy D, Vasan RS, Larson MG, Ellinor PT, Benjamin EJ. Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2015 May 12;131(19):1648-55. doi: 10.1161/CIRCULATIONAHA.114.014058. Epub 2015 Mar 13.</citation>
    <PMID>25769640</PMID>
  </results_reference>
  <results_reference>
    <citation>Walkey AJ, Hammill BG, Curtis LH, Benjamin EJ. Long-term outcomes following development of new-onset atrial fibrillation during sepsis. Chest. 2014 Nov;146(5):1187-1195. doi: 10.1378/chest.14-0003.</citation>
    <PMID>24723004</PMID>
  </results_reference>
  <results_reference>
    <citation>Gialdini G, Nearing K, Bhave PD, Bonuccelli U, Iadecola C, Healey JS, Kamel H. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA. 2014 Aug 13;312(6):616-22. doi: 10.1001/jama.2014.9143.</citation>
    <PMID>25117130</PMID>
  </results_reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 3, 2021</study_first_submitted>
  <study_first_submitted_qc>December 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>December 15, 2021</last_update_submitted>
  <last_update_submitted_qc>December 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rabin Medical Center</investigator_affiliation>
    <investigator_full_name>Katia Orvin</investigator_full_name>
    <investigator_title>Katia Orvin M.D - director of cardiac intensive care unit, Rabin Medical Center</investigator_title>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <keyword>intensive care unit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

